S. Michael Rothenberg, M.D., Ph.D.
DirectoratTyra Biosciences· In proxies 2024–2025
S. Michael Rothenberg, M.D., Ph.D. sits on 1 public board.
Experience
- Tyra BiosciencesPublic company · 2 yr
- Director2024 – Present · 2 yrStock in role +49%
- Annual MeetingPublic company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?